Find-A-Study

Viva Mind

Lay Description

A clinical trial to determine if Varoglutamstat (PQ912) is effective in slowing effects of Alzheimer's Disease

Eligibility

Eligible Ages: 50-89 inclusive
Eligible Genders: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Diagnosed with Mild Cognitive Impairment due to AD or Mild probable AD.

Have had an MRI w/in the Past Six Months

Have a study partner who has frequent interaction with the participant (3-4 times per week) and can accompany the participant to all visits.

Exclusion Criteria

Have been diagnosed with a disease known to cause dementia including (but not limited to) Parkinson's Disease, Huntington disease, Lewy Body Disease, or AIDS.

Have a mental illness judged to be not well controlled in the opinion of the PI.

Medical Contraindications to undergoing an MRI or Lumbar Puncture.

Have a medical condtion determined to be not well controlled on medication in the opinion of the PI.

Study Design

Arm Groups

Study Contact

Regulatory Point of Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu

Regulatory Point of Contact
Sudha Seshadri
(210) 450-8437
Seshadri@uthscsa.edu

Principal Investigator
Sudha Seshadri